VI
Viatris Inc
🇺🇸XNAS.VTRSUnited StatesHealthcare
$16.94USDup +0.28 (+1.68%)OpenDelayed5:08 PM
Price$16.94+0.28 (+1.68%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US92556V1061
- CUSIP
- 92556V106
Company
- Employees
- 30,000
- Headquarters
- Canonsburg, United States
- Website
- https://www.viatris.com
- CEO
- Mr. Scott Andrew Smith Ph.D.
Market
- Shares outstanding
- 1.1B
- Market cap
- $19.46B
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $19.14B
- EPS LTM
- -$0.35
- P/E LTM
- -44.84
- Div yield
- 3.03%
Fundamentals (LTM)
- Revenue
- $14.74B+4.4%up year on year
- Net income
- -$410.7M+88.16%up year on year
- Gross margin
- 34.83%-4.87%down year on year
- Free cash flow
- $1.87B+10.5%up year on year
Other listings
- XSTU.VIAStuttgart Stock Exchange
- XDUS.VIADüsseldorf Stock Exchange
- XETR.VIAXetra
- XFRA.VIAFrankfurt Stock Exchange
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.